The overexpression of BCAT2 in the human pancreatic cancer cell line Aspc-1 and hepatocellular carcinoma cells HepG2 increased intracellular glutamate and glutamate release, increased system Xc− activity, and inhibited ferroptosis. Here, BCAT2 is linked to pancreatic neoplasm.